Pneumococcal polysaccharide vaccine (PPV) 2023-2027

Finnish institute for health and welfare (hereinafter "THL" or “Customer” ) request your tender for pneumococcal polysaccharide vaccine (PPV) belonging to the National Vaccination Programme in Finland. The contract period is about four (4) years 2023 - 2027 and the estimated quantity for the contract period is 2000 (+/- 20 %) doses. The procurement contains additional procurement option for 1000 doses (+/- 20 %). The contract will be awarded to one Supplier based on a comparison of tenders. Call for Tenders, annexes: Annex 1 Minimum Requirements Concerning the Subject of Procurement (PPV) Annex 2 JYSE 2014 Supplies (updated version of April 2022) Annex 3 Handi Service Annex 4 Contract

The purpose of Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) is to procure pneumococcal polysaccharide vaccine (PPV) belonging to the National Vaccination Programme in Finland for risk groups. The tendered vaccine must be suitable for children over 2 years old and above. More information about National Vaccination Programme and vaccinations can be found on the website of the National Institute for Health and Welfare: https://thl.fi/en/web/infectious-diseases-and-vaccinations/vaccines-a-to-z/pneumococcal-vaccines/pneumococcal-polysaccharide-vaccine-ppv The subject of procurement and the mandatory requirements relating to it are described in detail in this Call for Tender and its annexes. The contract will be awarded to one Supplier based on a comparison of tenders. Tenders will be compared in the manner described in section "Grounds for decision" of the Call for Tenders.

This procurement is detailed in the contract notice published on the Hilma electronic procurement portal at www.hankintailmoitukset.fi as well as in this Call for Tenders and its Annexes.